Trusted News Discovery Since 2008
{{/content}}
Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death
Video Credit: Wochit News
Published on May 23, 2020 - Duration: 00:25s
Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death
Business Insider reports that a coronavirus vaccine my not be ready until the end of 2021, according to Roche, the world's second-largest pharmaceutical company.
He explained "According to the most likely scenario, we will not have a vaccination before the end of next year." Instead, Severin Schwan, chief executive of Roche, says that the public could have access to antibody tests sooner.
You are here
Related news from verified sources
The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to an increased risk...
on May 22, 2020 • Reuters India
The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to an increased risk...
on May 23, 2020 • Reuters India
"The authors reported that among patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate."
on May 26, 2020 • DNA
Related videos from verified sources
Study focuses on risks of breast cancer after pre-invasive disease 01:12
Video credit: ANI - Published on May 29, 2020
World Health Organization Halts Trials Of Hydroxychloroquine 00:38
Video credit: Wochit - Published on May 26, 2020
Explained: Why WHO suspended hydroxychloroquine trials | Covid-19 05:09
Video credit: HT Digital Content - Published on May 26, 2020